Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Clear Cell Renal Cell Carcinoma”
Phase 3 3
- CasdatifanArcus Biosciences, Inc.Advanced Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma
- Nivolumab andBRISTOL MYERS SQUIBB COClear Cell Renal Cell Carcinoma
- XL092EXELIXIS, INC.Non-Clear Cell Renal Cell Carcinoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.